Improved 6-month survival rate in subjects with prostate stem cell antigen (PSCA) positive tumours in a global, randomized phase 2 trial comparing gemcitabine vs. gemcitabine + Ags-1c4d4 (asp6182) in metastatic pancreatic cancer (mPC) Meeting Abstract
| Authors: | Wolpin, B. M.; O'Reilly, E. M.; Ko, Y. J.; Lima, M. S. R.; Spratlin, J. L.; Macarulla, T.; Pezet, D.; Hartford, A.; Jackson, L. S.; Hidalgo, M. |
| Abstract Title: | Improved 6-month survival rate in subjects with prostate stem cell antigen (PSCA) positive tumours in a global, randomized phase 2 trial comparing gemcitabine vs. gemcitabine + Ags-1c4d4 (asp6182) in metastatic pancreatic cancer (mPC) |
| Meeting Title: | 16th ECCO - 36th ESMO - 30th ESTRO European Multidisciplinary Cancer Congress (EMCC 2011) |
| Journal Title: | European Journal of Cancer |
| Volume: | 47 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2011 Sep 23-27 |
| Meeting Location: | Stockholm, Sweden |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2011-09-01 |
| Start Page: | S469 |
| Language: | English |
| ACCESSION: | WOS:000295752801628 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(11)71902-5 |
| Notes: | --- - Meeting Abstract: 6591 - European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care - SEP 23-27, 2011 - Stockholm, SWEDEN - "Source: Wos" |
